Intraperitoneal inoculation of L1210 murine
leukemia cell
vaccine increased
I-Ad antigen-positive and -negative macrophages in the peritoneal cavity of histocompatible mice.
Mitomycin C, a poor producer of
I-Ad antigen-positive macrophages, selectively augmented the production of
I-Ad antigen-positive macrophages in L1210
vaccine-primed mice, since it did not augment the production of non-macrophage cells. Since our previous study showed that the priming of mice with L1210
vaccine and
mitomycin C induced augmented antitumor response, we tested the feasibility of the association of
mitomycin C-augmented
I-Ad antigen-positive macrophages with the augmented antitumor response.
Prostaglandin E2 suppressed the antitumor response in L1210
vaccine- and
mitomycin C-primed mice and, consistent with this, it inhibited the production of
I-Ad antigen-positive macrophages, although it inhibited the production of non-macrophage cells as well. This hypothesis was further tested by the use of
silica. When L1210
vaccine- and
mitomycin C-primed mice were further given
silica on the day of and one day after live L1210 inoculation, their antitumor response was strongly suppressed, while a kinetic analysis of the cellularity of peritoneal cells showed that administration of
silica resulted in a decrease of
I-Ad antigen-positive macrophages, but not
I-Ad antigen-negative macrophages or non-macrophage cells in these mice. These results strongly suggest, though they do not prove, the association of
mitomycin C-augmented production of
I-Ad antigen-positive macrophages with the antitumor response in L1210
vaccine- and
mitomycin C-primed mice.